Skip to content
Application 204217
- Type
- ANDA
- Sponsor
- GLAND PHARMA LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | ZOLEDRONIC ACID | ZOLEDRONIC ACID | INJECTABLE;INTRAVENOUS | EQ 5MG BASE/100ML | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 63323-966 | Zoledronic Acid | Zoledronic Acid | Fresenius Kabi USA, LLC | ANDA | Current |
| 63323-966 | Zoledronic Acid | Zoledronic Acid | Fresenius Kabi USA, LLC | ANDA | Current |
| 68083-135 | Zoledronic Acid | Zoledronic Acid | Gland Pharma Limited | ANDA | Current |
| 68083-135 | Zoledronic Acid | Zoledronic Acid | Gland Pharma Limited | ANDA | Current |